185 related articles for article (PubMed ID: 19728514)
1. Giant leaps forward.
Trainer P
Clin Med (Lond); 2009 Aug; 9(4):363-4. PubMed ID: 19728514
[No Abstract] [Full Text] [Related]
2. Growth-hormone and prolactin excess.
Colao A; Lombardi G
Lancet; 1998 Oct; 352(9138):1455-61. PubMed ID: 9808008
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and tolerability of somatostatin analogs and other therapies for acromegaly.
Burt MG; Ho KK
Endocrine; 2003 Apr; 20(3):299-305. PubMed ID: 12721511
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analogs in medical treatment of acromegaly.
Racine MS; Barkan AL
Endocrine; 2003 Apr; 20(3):271-8. PubMed ID: 12721507
[TBL] [Abstract][Full Text] [Related]
5. Giant prolactinoma: where's the prolactin?
Tailor C; Teo I; Sorisky A
Clin Neurol Neurosurg; 2011 Nov; 113(9):810-2. PubMed ID: 21906866
[No Abstract] [Full Text] [Related]
6. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches.
Iglesias P; Rodríguez Berrocal V; Díez JJ
Endocrine; 2018 Sep; 61(3):407-421. PubMed ID: 29909598
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of pituitary diseases. What can be achieved with medication and hormones?].
Schopohl J; Gutt B
MMW Fortschr Med; 2001 Nov; 143(44):34-9. PubMed ID: 11732393
[TBL] [Abstract][Full Text] [Related]
8. [Management of pituitary adenoma in pregnancy].
Cheng W; Zhang Z
Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):537-9. PubMed ID: 9275425
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours.
Colao A; Filippella M; Pivonello R; Di Somma C; Faggiano A; Lombardi G
Eur J Endocrinol; 2007 Apr; 156 Suppl 1():S57-S63. PubMed ID: 17413190
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological therapy for acromegaly: a critical review.
Muller AF; Van Der Lely AJ
Drugs; 2004; 64(16):1817-38. PubMed ID: 15301564
[TBL] [Abstract][Full Text] [Related]
11. [Prolactinoma; diagnosis and treatment].
van der Lely AJ; de Herder WW; Hofland LJ; Lamberts SW
Ned Tijdschr Geneeskd; 1996 Jul; 140(28):1445-9. PubMed ID: 8766768
[No Abstract] [Full Text] [Related]
12. Prolactinoma and pregnancy.
Randeva HS; Davis M; Prelevic GM
BJOG; 2000 Sep; 107(9):1064-8. PubMed ID: 11002946
[No Abstract] [Full Text] [Related]
13. The therapeutic value of somatostatin and its analogues.
Farooqi S; Bevan JS; Sheppard MC; Wass JA
Pituitary; 1999 Jun; 2(1):79-88. PubMed ID: 11081176
[TBL] [Abstract][Full Text] [Related]
14. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
[TBL] [Abstract][Full Text] [Related]
16. Case series of equine pituitary pars intermedia dysfunction in a tropical climate.
Spelta CW; Axon JE
Aust Vet J; 2012 Nov; 90(11):451-6. PubMed ID: 23106327
[TBL] [Abstract][Full Text] [Related]
17. Acromegaly.
Sassolas G
Curr Ther Endocrinol Metab; 1994; 5():44-8. PubMed ID: 7704770
[No Abstract] [Full Text] [Related]
18. Somatostatin analogs in the treatment of acromegaly: the choice is now possible.
Chanson P
Eur J Endocrinol; 2000 Nov; 143(5):573-5. PubMed ID: 11078979
[No Abstract] [Full Text] [Related]
19. Evidence for dopamine agonists in the treatment of acromegaly.
Jaquet P
J Endocrinol; 1997 Oct; 155 Suppl 1():S59-60. PubMed ID: 9389998
[No Abstract] [Full Text] [Related]
20. Current status and future directions of pharmacological therapy for acromegaly.
Mercado M; Espinosa E; Ramírez C
Minerva Endocrinol; 2016 Sep; 41(3):351-65. PubMed ID: 26485036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
